Literature DB >> 8763931

Expression of sialic acid and polysialic acid in serogroup B Neisseria meningitidis: divergent transcription of biosynthesis and transport operons through a common promoter region.

J S Swartley1, J H Ahn, L J Liu, C M Kahler, D S Stephens.   

Abstract

We studied capsule-defective (Cap-) serogroup B meningococcal mutants created through Tn916 or omega-fragment mutagenesis. The Cap- phenotypes were the results of insertions in three of four linked genes (synX, synC, and synD) involved in CMP-N-acetylneuraminic acid and polysialic acid capsule biosynthesis, and in ctrA the first of four linked genes involved in capsule membrane transport. Mutations in the CMP-N-acetylneuraminic acid biosynthesis genes synX and synC caused defects in lipooligosaccharide sialylation but not mutations in the putative (alpha2 -> 8)-linked polysialyltransferase (synD) or in ctrA. Reverse transcriptase PCR studies indicated that the four biosynthesis genes (synX to -D) and the capsule transport genes (ctr to -D) were separately transcribed as operons. The operons were separated by a 134-bp intergenic region. Primer extension of synX and ctrA demonstrated that transcription of the operons was divergently initiated from adjacent start sites present in the intergenic region. Both transcriptional start sites were preceded by a perfect -10 Pribnow promoter binding region. The synX to -D, but not the ctrA to -D, transcriptional start site was preceded by a sequence bearing strong homology to the consensus sigma 70 -35 promoter binding sequence. Both promoters showed transcriptional activity when cloned behind a lacZ reporter gene in Escherichia coli. Our results confirm the intrinsic relationship between polysialic acid capsule biosynthesis and lipooligosaccharide sialylation pathways in group B Neisseria meningitidis. Our study also suggests that the intergenic region separating the synX to -D and ctrA to -D operons is an important control point for the regulation of group B capsule expression through coordinated transcriptional regulation of the synX to -D and drA to -D promoters.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8763931      PMCID: PMC178160          DOI: 10.1128/jb.178.14.4052-4059.1996

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  49 in total

1.  An IgG monoclonal antibody to group B meningococci cross-reacts with developmentally regulated polysialic acid units of glycoproteins in neural and extraneural tissues.

Authors:  J Finne; D Bitter-Suermann; C Goridis; U Finne
Journal:  J Immunol       Date:  1987-06-15       Impact factor: 5.422

2.  Antigenic similarities between brain components and bacteria causing meningitis. Implications for vaccine development and pathogenesis.

Authors:  J Finne; M Leinonen; P H Mäkelä
Journal:  Lancet       Date:  1983-08-13       Impact factor: 79.321

3.  The minus 35-recognition region of Escherichia coli sigma 70 is inessential for initiation of transcription at an "extended minus 10" promoter.

Authors:  A Kumar; R A Malloch; N Fujita; D A Smillie; A Ishihama; R S Hayward
Journal:  J Mol Biol       Date:  1993-07-20       Impact factor: 5.469

4.  Transposition and fusion of the lac genes to selected promoters in Escherichia coli using bacteriophage lambda and Mu.

Authors:  M J Casadaban
Journal:  J Mol Biol       Date:  1976-07-05       Impact factor: 5.469

5.  In vitro insertional mutagenesis with a selectable DNA fragment.

Authors:  P Prentki; H M Krisch
Journal:  Gene       Date:  1984-09       Impact factor: 3.688

6.  A comprehensive set of sequence analysis programs for the VAX.

Authors:  J Devereux; P Haeberli; O Smithies
Journal:  Nucleic Acids Res       Date:  1984-01-11       Impact factor: 16.971

7.  Factors affecting autolysis of Neisseria gonorrhoeae.

Authors:  S A Morse; L Bartenstein
Journal:  Proc Soc Exp Biol Med       Date:  1974-04

8.  Modulation of cell surface sialic acid expression in Neisseria meningitidis via a transposable genetic element.

Authors:  S Hammerschmidt; R Hilse; J P van Putten; R Gerardy-Schahn; A Unkmeir; M Frosch
Journal:  EMBO J       Date:  1996-01-02       Impact factor: 11.598

9.  The Stonehouse survey: nasopharyngeal carriage of meningococci and Neisseria lactamica.

Authors:  K A Cartwright; J M Stuart; D M Jones; N D Noah
Journal:  Epidemiol Infect       Date:  1987-12       Impact factor: 2.451

10.  Human immunity to the meningococcus. 3. Preparation and immunochemical properties of the group A, group B, and group C meningococcal polysaccharides.

Authors:  E C Gotschlich; T Y Liu; M S Artenstein
Journal:  J Exp Med       Date:  1969-06-01       Impact factor: 14.307

View more
  25 in total

1.  Characterization and acceptor preference of a soluble meningococcal group C polysialyltransferase.

Authors:  Dwight C Peterson; Gayathri Arakere; Justine Vionnet; Pumtiwitt C McCarthy; Willie F Vann
Journal:  J Bacteriol       Date:  2011-01-28       Impact factor: 3.490

2.  Genetic basis for biosynthesis of the (alpha 1-->4)-linked N-acetyl-D-glucosamine 1-phosphate capsule of Neisseria meningitidis serogroup X.

Authors:  Yih-Ling Tzeng; Corie Noble; David S Stephens
Journal:  Infect Immun       Date:  2003-12       Impact factor: 3.441

3.  Biofilm formation by Neisseria meningitidis.

Authors:  Kyungcheol Yi; Andrew W Rasmussen; Seshu K Gudlavalleti; David S Stephens; Igor Stojiljkovic
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

4.  Distribution of serogroups and genotypes among disease-associated and carried isolates of Neisseria meningitidis from the Czech Republic, Greece, and Norway.

Authors:  Siamak P Yazdankhah; Paula Kriz; Georgina Tzanakaki; Jenny Kremastinou; Jitka Kalmusova; Martin Musilek; Torill Alvestad; Keith A Jolley; Daniel J Wilson; Noel D McCarthy; Dominique A Caugant; Martin C J Maiden
Journal:  J Clin Microbiol       Date:  2004-11       Impact factor: 5.948

Review 5.  Biology and pathogenesis of the evolutionarily successful, obligate human bacterium Neisseria meningitidis.

Authors:  David S Stephens
Journal:  Vaccine       Date:  2009-05-23       Impact factor: 3.641

6.  New mobilizable vectors suitable for gene replacement in gram-negative bacteria and their use in mapping of the 3' end of the Xanthomonas campestris pv. campestris gum operon.

Authors:  F Katzen; A Becker; M V Ielmini; C G Oddo; L Ielpi
Journal:  Appl Environ Microbiol       Date:  1999-01       Impact factor: 4.792

7.  De-N-acetylated sialic acid is immunogenic and elicits antibodies that are protective against Neisseria meningitidis.

Authors:  Gregory R Moe; Becca A Flitter; Jessica Y Ing; Tamara S Bhandari; Hardeep Kaur
Journal:  Vaccimonitor       Date:  2009

8.  The (alpha2-->8)-linked polysialic acid capsule and lipooligosaccharide structure both contribute to the ability of serogroup B Neisseria meningitidis to resist the bactericidal activity of normal human serum.

Authors:  C M Kahler; L E Martin; G C Shih; M M Rahman; R W Carlson; D S Stephens
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

Review 9.  Mechanisms in Neisseria meningitidis for resistance against complement-mediated killing.

Authors:  Elisabeth Kugelberg; Bridget Gollan; Christoph M Tang
Journal:  Vaccine       Date:  2008-12-30       Impact factor: 3.641

10.  Use of nfsB, encoding nitroreductase, as a reporter gene to determine the mutational spectrum of spontaneous mutations in Neisseria gonorrhoeae.

Authors:  Daniel C Stein; Esteban Carrizosa; Stephen Dunham
Journal:  BMC Microbiol       Date:  2009-11-23       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.